Decoding the genetic links between diabetes, hyperlipidemia, and IBD

Announcing a new publication for Acta Materia Medica journal. Previous epidemiologic studies have shown a close association between type 1 diabetes mellitus (T1DM), hyperlipidemia, and inflammatory bowel disease (IBD), but the causal relationship has not been established. The authors of this articles assessed the causal relationships between T1DM and hyperlipidemia with IBD using Mendelian randomization (MR) analysis.

A two-sample MR study was conducted utilizing accessible genome-wide association study data from public sources with the selection of suitable instrumental variables adhering to the principles of MR analysis. The primary technique utilized was the inverse variance weighted method, complemented by additional methods, such as MR-Egger regression, weighted median, simple mode, weighted mode, and the MR pleiotropy residual sum and outlier approach. Genetically determined T1DM had no causal relationship with IBD or IBD subtypes based on MR analysis.

These findings were consistent across all supplementary methods used. In addition, genetically determined hyperlipidemia had no causal relationship with IBD or IBD subtypes, even after increasing the number of instrumental variables used. The study supports the notion that there is no causal relationship between T1DM and IBD, as well as hyperlipidemia and IBD, which contradicts most observational studies.

 

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Global gap in diabetes prevalence and treatment has widened since 1990